Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 13 January 2026

Woodside Energy stock dips after Scarborough LNG milestone — what matters before the next ASX session

Woodside Energy stock dips after Scarborough LNG milestone — what matters before the next ASX session

Woodside shares fell 1.7% to A$23.31 after the company warned on a key Scarborough project milestone, despite its floating production unit arriving at the offshore site. The project is now over 91% complete, with first LNG cargo still slated for the second half of 2026. Traders are watching oil prices and Woodside’s Jan. 28 update for further direction.
13 January 2026
···
Japan Airlines stock slips as CEO warns young Japanese are ditching overseas travel

Japan Airlines stock slips as CEO warns young Japanese are ditching overseas travel

Japan Airlines shares dropped 1.4% to 2,949 yen Tuesday as investors questioned outbound travel demand amid a weak yen. CEO Mitsuko Tottori cited high prices and currency pressure as factors keeping young Japanese from traveling abroad. The yen hit 158.925 per dollar, raising costs for overseas trips and airline operations. JAL is targeting youth with promotions and discounted fares while relying on inbound tourism.
13 January 2026
··
ANZ share price jumps as Morgan Stanley flags a rare repeat win — what to watch next for ASX:ANZ

ANZ share price jumps as Morgan Stanley flags a rare repeat win — what to watch next for ASX:ANZ

ANZ Group Holdings closed up 1.6% at A$36.48 in Sydney, outperforming major peers as the S&P/ASX 200 rose 0.56%. Morgan Stanley kept its equal-weight rating on ANZ, setting a target of A$36 and warning of a wider performance gap among banks in 2026. Investors are watching for Australia’s Jan. 28 CPI data and the RBA’s Feb. 2–3 meeting amid renewed rate-hike speculation. Consumer sentiment fell 1.7% in January, Westpac said.
13 January 2026
·
CSL share price slips after ASX close: what investors watch next for ASX:CSL ahead of February results

CSL share price slips after ASX close: what investors watch next for ASX:CSL ahead of February results

CSL Ltd shares fell 1.0% to A$173.32 Tuesday, underperforming the S&P/ASX 200, which rose 0.56%. The drop follows last year’s cut to CSL’s FY26 forecasts and a delay to the Seqirus spin-off after a sharp decline in U.S. flu vaccinations. No new company updates were released Tuesday. CSL’s next scheduled disclosure is its half-year results on Feb. 11.
13 January 2026
···
PLS Group stock hits a 52-week high as China lithium surges — what investors watch next

PLS Group stock hits a 52-week high as China lithium surges — what investors watch next

PLS Group Limited shares rose 1.9% to A$4.86, nearing a 52-week high and valuing the company at about A$15.7 billion. The move followed a 7.2% jump in Chinese lithium carbonate futures after China announced plans to cut VAT export rebates on battery products. Investors are watching if the rally leads to sustained demand or a short-term spike. PLS will release its December-quarter report on Jan. 30.
13 January 2026
··
CBA stock rises after new wage data — what to watch before Commonwealth Bank’s Feb results

CBA stock rises after new wage data — what to watch before Commonwealth Bank’s Feb results

Commonwealth Bank shares rose 0.8% to A$155.36 as major Australian banks advanced on renewed rate hike speculation. CBA’s wage tracker showed 0.8% quarterly pay growth and steady unemployment at 4.3%. The ASX 200 closed up 0.6%. Investors await CBA’s half-year results on Feb. 11 for margin and credit quality details.
13 January 2026
·····
Northern Star stock jumps 3.6% as gold holds near record highs — here’s what traders watch next

Northern Star stock jumps 3.6% as gold holds near record highs — here’s what traders watch next

Northern Star Resources shares rose 3.6% to A$26.35 as gold prices hovered near record highs. The miner cut its FY26 gold sales forecast after reporting disruptions at key sites, including a crusher failure at KCGM and downtime at Thunderbox. Investors await a quarterly update on costs and output due late January. Turnover reached about A$133 million on the ASX.
13 January 2026
··
BHP stock rises as it stays out of the Rio-Glencore chase — what investors watch next

BHP stock rises as it stays out of the Rio-Glencore chase — what investors watch next

BHP’s U.S. shares rose 1.7% to $62.80 after sources said the miner won’t pursue a rival bid for Glencore, instead watching Rio Tinto’s takeover talks. BHP declined to comment. Rio Tinto’s U.S. shares gained 2.1% to $82.88, while Freeport-McMoRan jumped 3.8%. BHP granted nearly 4 million performance rights in a routine filing, listing 5.08 billion shares outstanding.
13 January 2026
····
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 13.01.2026

WHSP Holdings insiders, led by Robert Millner, bought AU$3.4 million in shares over 12 months with no insider sales; insiders now hold 5.4% of the company. JPMorgan Chase dropped over 3% midday after missing estimates, while Moderna surged 14% on a strong 2025 sales forecast. Arch Capital Group trades near $90.77 as momentum slows, with analysts’ targets averaging $108.31. BofA Securities upgraded Coinbase Global to Buy, setting a $340 target.
13 January 2026
·····
Adobe stock slides as Goldman turns bearish; CPI and Firefly AI push set up Tuesday

Adobe stock slides as Goldman turns bearish; CPI and Firefly AI push set up Tuesday

Adobe fell 1.9% to $327.65 Monday, underperforming the S&P 500 and Dow, after Goldman Sachs initiated coverage with a Sell rating and $290 target. The stock is about 30% below its 52-week high amid analyst skepticism over AI monetization and competitive pressure. Trading volume was slightly below average. Investors await December CPI data Tuesday morning.
13 January 2026
···
Merck stock in focus as MRK lifts $70 billion mid-2030s target and points past Keytruda

Merck stock in focus as MRK lifts $70 billion mid-2030s target and points past Keytruda

Merck raised its long-term revenue forecast for new products to $70 billion by the mid-2030s, lifting its cardiometabolic and respiratory outlook to $20 billion and infectious disease to $15 billion. Shares fell 1.2% to $109.19. Johnson & Johnson rose 2.6%, Eli Lilly gained 1.6%, and Pfizer slipped 0.8%. Merck said its pipeline could offset Keytruda’s loss of exclusivity by 2026.
13 January 2026
··
Oklo stock slips as insiders sell shares and traders reassess Meta nuclear deal

Oklo stock slips as insiders sell shares and traders reassess Meta nuclear deal

Oklo Inc shares fell 2.7% to $102.50 Monday, reversing some of last week’s surge after Meta Platforms announced a 20-year nuclear power deal involving Oklo. A regulatory filing showed Oklo COO Caroline Cochran sold 328,372 shares for about $32.5 million last week. Oklo said Meta’s agreement supports a planned 1.2-gigawatt power campus in Ohio, with first power targeted for 2030.
13 January 2026
·
Texas Instruments stock dips into CPI week as TXN heads toward earnings

Texas Instruments stock dips into CPI week as TXN heads toward earnings

Texas Instruments shares fell 0.7% to $189.07 on Monday, lagging behind record highs in the S&P 500 and Dow. Investors are watching Tuesday’s U.S. inflation data and Texas Instruments’ Jan. 27 earnings for signals on industrial demand. Semiconductor stocks showed mixed moves, with Qualcomm and Analog Devices posting steeper declines. The average analyst target for Texas Instruments stands at $190.40.
13 January 2026
···
KLA stock notches new 52-week high as chip-tool shares firm; Susquehanna lifts target

KLA stock notches new 52-week high as chip-tool shares firm; Susquehanna lifts target

KLA shares rose 2.0% to a record $1,428.17 Monday after Susquehanna raised its price target to $1,500, maintaining a Neutral rating. Trading volume was 854,084 shares, below average. Applied Materials gained 2.0% and Lam Research added nearly 1.0%, lifting the iShares Semiconductor ETF by about 0.5%. KLA reports fiscal Q2 results Jan. 29 after market close.
13 January 2026
··
1 … 363 364 365 366 367 … 1,170

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop